|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Cash and due from banks | ||||||||||||||||||||
| Federal funds sold | ||||||||||||||||||||
| Interest-earning deposits | ||||||||||||||||||||
| Total cash and cash equivalents | ||||||||||||||||||||
| Interest-earning deposits greater than 90 days | ||||||||||||||||||||
| Securities available-for-sale | ||||||||||||||||||||
| Securities held-to-maturity, net | ||||||||||||||||||||
| Loans held-for-sale | ||||||||||||||||||||
| Allowance for credit losses on loans | ||||||||||||||||||||
| Loans, before unearned loan fees | ||||||||||||||||||||
| ACL on loans | ||||||||||||||||||||
| Total loans, net | ||||||||||||||||||||
| Other investments | ||||||||||||||||||||
| Fixed assets, net | ||||||||||||||||||||
| Accrued interest receivable | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Other assets | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and Stockholders' Equity | ||||||||||||||||||||
| Noninterest-bearing demand accounts | ||||||||||||||||||||
| Interest-bearing demand accounts | ||||||||||||||||||||
| Money market accounts | ||||||||||||||||||||
| Savings accounts | ||||||||||||||||||||
| Certificates of deposit: | ||||||||||||||||||||
| Brokered | ||||||||||||||||||||
| Customer | ||||||||||||||||||||
| Total deposits | ||||||||||||||||||||
| Subordinated debentures and notes | ||||||||||||||||||||
| FHLB advances | ||||||||||||||||||||
| Other borrowings | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Stockholders’ equity: | ||||||||||||||||||||
| Preferred stock, $0.01 par value; 5,000,000 shares authorized; 75,000 shares issued and outstanding ($1,000 per share liquidation preference) | ||||||||||||||||||||
| Common stock, $0.01 par value; 75,000,000 shares authorized; 36,257,707 and 36,965,398 shares issued and outstanding | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Retained earnings | ||||||||||||||||||||
| Accumulated other comprehensive loss, net | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...
